ClinConnect ClinConnect Logo
Search / Trial NCT05732649

Improving Visual Perception and Visuo-motor Learning With Neurofeedback of Brain Network Interaction.

Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Feb 8, 2023

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to improve how the brain communicates during tasks that involve seeing and moving. Researchers are investigating a technique called neurofeedback, which gives people real-time information about their brain activity. This feedback helps individuals learn to enhance the communication between different parts of their brain when they are at rest, which may lead to better visual perception and motor learning when they do engage in tasks.

To participate in this study, you need to be at least 18 years old and have normal or corrected vision. You should not have any neurological or psychiatric conditions, and you should not regularly use certain medications that affect the brain. Participants will receive guidance on how to use neurofeedback to potentially improve their brain function. If you’re interested in being part of this exciting research, it’s a chance to contribute to understanding how we can train our brains to work better together!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Signed informed consent
  • Age at least 18 years old
  • Normal or corrected-to-normal vision
  • No neurological or psychiatric diseases
  • No regular consumption of benzodiazepines or neuroleptics
  • Exclusion Criteria:
  • Any surgical intervention to the brain
  • Drug or alcohol abuse
  • Presence of non-MRI safe metal in the body

About Insel Gruppe Ag, University Hospital Bern

Insel Gruppe AG, the umbrella organization for the University Hospital Bern, is a leading healthcare provider in Switzerland, renowned for its commitment to advancing medical research and patient care. As a key player in clinical trials, Insel Gruppe AG integrates cutting-edge scientific inquiry with clinical excellence, facilitating innovative studies that span a wide range of medical disciplines. The institution prioritizes collaboration with academic partners and industry stakeholders to enhance the understanding of diseases and develop effective treatment options, ultimately aiming to improve patient outcomes and contribute to the global medical community.

Locations

Bern, , Switzerland

Patients applied

0 patients applied

Trial Officials

Adrian Guggisberg, Prof. Dr.

Principal Investigator

Division of Neurorehabilitation, Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials